Search Results

There are 11780 results for: content related to: Treatment of systemic lupus erythematosus: new advances in targeted therapy

  1. The role of B cell–activating factor in autoimmune myasthenia gravis

    Annals of the New York Academy of Sciences

    Volume 1274, Issue 1, December 2012, Pages: 60–67, Robert P. Lisak and Samia Ragheb

    Version of Record online : 17 DEC 2012, DOI: 10.1111/j.1749-6632.2012.06842.x

  2. You have free access to this content
    BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus

    IUBMB Life

    Volume 64, Issue 7, July 2012, Pages: 595–602, Kirsten Fairfax, Ian R. Mackay and Fabienne Mackay

    Version of Record online : 29 MAY 2012, DOI: 10.1002/iub.1046

  3. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  4. You have free access to this content
    Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 64, Issue 7, July 2012, Pages: 2328–2337, William Stohl, Falk Hiepe, Kevin M. Latinis, Mathew Thomas, Morton A. Scheinberg, Ann Clarke, Cynthia Aranow, Frank R. Wellborne, Carlos Abud-Mendoza, Douglas R. Hough, Lilia Pineda, Thi-Sau Migone, Z. John Zhong, William W. Freimuth, W. Winn Chatham and on behalf of the BLISS-52 and BLISS-76 Study Groups

    Version of Record online : 26 JUN 2012, DOI: 10.1002/art.34400

  5. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  6. You have free access to this content
    Biologic agents in the treatment of glomerulonephritides

    Nephrology

    Volume 20, Issue 11, November 2015, Pages: 767–787, See Cheng Yeo and Adrian Liew

    Version of Record online : 7 OCT 2015, DOI: 10.1111/nep.12530

  7. Belimumab: A BLyS-Specific Inhibitor for the Treatment of Systemic Lupus Erythematosus

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 1, January 2012, Pages: 143–149, G J Dennis

    Version of Record online : 30 NOV 2011, DOI: 10.1038/clpt.2011.290

  8. You have free access to this content
    Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 64, Issue 10, October 2012, Pages: 3364–3373, Joan T. Merrill, Ellen M. Ginzler, Daniel J. Wallace, James D. McKay, Jeffrey R. Lisse, Cynthia Aranow, Frank R. Wellborne, Michael Burnette, John Condemi, Z. John Zhong, Lilia Pineda, Jerry Klein, William W. Freimuth and on behalf of the LBSL02/99 Study Group

    Version of Record online : 27 SEP 2012, DOI: 10.1002/art.34564

  9. Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus

    Arthritis Care & Research

    Accepted manuscript online: 7 JUL 2016, Luca Iaccarino, Silvano Bettio, Rossella Reggia, Margherita Zen, Micol Frassi, Laura Andreoli, Mariele Gatto, Silvia Piantoni, Linda Nalotto, Franco Franceschini, Maddalena Larosa, Micaela Fredi, Leonardo Punzi, Angela Tincani and Andrea Doria

    DOI: 10.1002/acr.22971

  10. Belimumab therapy for systemic lupus erythematosus and potential treatment of rheumatoid arthritis

    Drug Development Research

    Volume 72, Issue 7, November 2011, Pages: 623–633, Changhai Ding, Ran Li, Jianhua Xu, Flavia Cicuttini and Graeme Jones

    Version of Record online : 23 NOV 2011, DOI: 10.1002/ddr.20472

  11. You have free access to this content
    Belimumab: targeted therapy for lupus

    International Journal of Rheumatic Diseases

    Volume 16, Issue 1, February 2013, Pages: 4–13, Preeta K. Chugh and Bhupinder S. Kalra

    Version of Record online : 19 OCT 2012, DOI: 10.1111/1756-185x.12002

  12. You have free access to this content
    Meeting Abstracts from The 13th International Symposium on Sjögren's Syndrome Bergen, Norway, May 19–22, 2015

    Scandinavian Journal of Immunology

    Volume 81, Issue 5, May 2015, Pages: 328–450,

    Version of Record online : 21 APR 2015, DOI: 10.1111/sji.12291

  13. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors

    Arthritis & Rheumatology

    Volume 67, Issue 9, September 2015, Pages: 2523–2535, Chaim O. Jacob, Ning Yu, Vishal Sindhava, Michael P. Cancro, Rahul D. Pawar, Chaim Putterman and William Stohl

    Version of Record online : 26 AUG 2015, DOI: 10.1002/art.39210

  14. You have free access to this content
    A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 63, Issue 12, December 2011, Pages: 3918–3930, Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J. Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T. Merrill, W. Winn Chatham, William Stohl, Ellen M. Ginzler, Douglas R. Hough, Z. John Zhong, William Freimuth, Ronald F. van Vollenhoven and BLISS-76 Study Group

    Version of Record online : 29 NOV 2011, DOI: 10.1002/art.30613

  15. You have free access to this content
    A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

    Arthritis Care & Research

    Volume 61, Issue 9, 15 September 2009, Pages: 1168–1178, Daniel J. Wallace, William Stohl, Richard A. Furie, Jeffrey R. Lisse, James D. McKay, Joan T. Merrill, Michelle A. Petri, Ellen M. Ginzler, W. Winn Chatham, W. Joseph McCune, Vivian Fernandez, Marc R. Chevrier, Z. John Zhong and William W. Freimuth

    Version of Record online : 27 AUG 2009, DOI: 10.1002/art.24699

  16. You have free access to this content
    The Plant Vascular System: Evolution, Development and Functions

    Journal of Integrative Plant Biology

    Volume 55, Issue 4, April 2013, Pages: 294–388, William J. Lucas, Andrew Groover, Raffael Lichtenberger, Kaori Furuta, Shri-Ram Yadav, Ykä Helariutta, Xin-Qiang He, Hiroo Fukuda, Julie Kang, Siobhan M. Brady, John W. Patrick, John Sperry, Akiko Yoshida, Ana-Flor López-Millán, Michael A. Grusak and Pradeep Kachroo

    Version of Record online : 10 APR 2013, DOI: 10.1111/jipb.12041

  17. Biologic therapies in systemic lupus erythematosus

    International Journal of Rheumatic Diseases

    Volume 18, Issue 2, February 2015, Pages: 146–153, Christine B. Bernal, Leonid D. Zamora and Sandra V. Navarra

    Version of Record online : 17 APR 2015, DOI: 10.1111/1756-185X.12490

  18. You have full text access to this OnlineOpen article
    Unfolded protein response to autophagy as a promising druggable target for anticancer therapy

    Annals of the New York Academy of Sciences

    Volume 1271, Issue 1, October 2012, Pages: 20–32, Dong Hoon Suh, Mi-Kyung Kim, Hee Seung Kim, Hyun Hoon Chung and Yong Sang Song

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1749-6632.2012.06739.x

  19. Induction of gut IgA production through T cell-dependent and T cell-independent pathways

    Annals of the New York Academy of Sciences

    Volume 1247, Issue 1, January 2012, Pages: 97–116, Mats Bemark, Preben Boysen and Nils Y. Lycke

    Version of Record online : 19 JAN 2012, DOI: 10.1111/j.1749-6632.2011.06378.x

  20. The oxazolidinones: past, present, and future

    Annals of the New York Academy of Sciences

    Volume 1241, Issue 1, December 2011, Pages: 48–70, Karen Joy Shaw and Michael R. Barbachyn

    Version of Record online : 22 DEC 2011, DOI: 10.1111/j.1749-6632.2011.06330.x